Jacob Vogelstein is the Co-Founder and Managing Partner of Catalio Capital Management, LP. He is primarily responsible for managing the firm and for making investments in private breakthrough biomedical technology companies.
R. Jacob Vogelstein - Catalio Capital Management | LinkedIn
www.linkedin.com › r-jacob-vogelstein-...
Experience: Catalio Capital Management · Location: Washington · 500+ connections on LinkedIn. View R. Jacob Vogelstein's profile on LinkedIn, a professional ...
Jacob received this honor for his work at the Intelligence Advanced Research Projects Activity where he is the program manager of the Machine Intelligence from ...
Co-Founder and Managing Partner of @CatalioCapital, a multi-strategy life science investment firm specializing in breakthrough drugs, devices, ...
Apr 9, 2024 · Trends, Statistics, and Insights for Understanding Today's Biotech Funding Landscape. 15.
R. Jacob Vogelstein received a Ph.D. in Biomedical Engineering from the Johns Hopkins University in May 2007. He is currently working at the Johns Hopkins ...
Dynamically reconfigurable silicon array of spiking neurons with conductance-based synapses. RJ Vogelstein, U Mallik, JT Vogelstein, G Cauwenberghs. IEEE ...
R Jacob Vogelstein is Managing Partner/Co-Founder at Catalio Capital Management LP. See R Jacob Vogelstein's compensation, career history, education, ...
R. Jacob Vogelstein Ph.D holds 5 board seats including Clasp Therapeutics, Haystack Oncology, Iambic Therapeutics, NextPoint, and Pheast Therapeutics.
Jan 11, 2017 · Jacob Vogelstein is a Partner and Portfolio Manager at Camden Partners Holdings, LLC, where he focuses on Camden's seed strategy.